Effect of the colloids gelatin and HES 130/0.4 on blood coagulation in cardiac surgery patients: A randomized controlled trial

Perfusion (United Kingdom)

Volumn 28, Issue 6, 2013, Pages 512-519

  Kimenai, D M ^a   Bastianen, G W ^a   Daane, C R ^a   Megens Bastiaanse, C M ^a   Van Der Meer, Njm ^a   Scohy, T V ^a   Gerritse, B M ^a  

^a AMPHIA HOSPITAL   (Netherlands)

Author keywords

coagulation; colloids; gelatin; hetastarch; thromboelastography

Indexed keywords

GELATIN SUCCINATE; HEPARIN; HETASTARCH; MANNITOL; RINGER LACTATE SOLUTION;

AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CHEST TUBE; COLLOID; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

COAGULATION; COLLOIDS; GELATIN; HETASTARCH; THROMBOELASTOGRAPHY;

AGED; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; COLLOIDS; FEMALE; GELATIN; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; ISOTONIC SOLUTIONS; MALE; SUCCINATES;

EID: 84887219072     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659113491446     Document Type: Article

References (23)

1. Despotis GJ, Avidan MS, Hogue CW. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg. 2001 ; 72: S1821-1831
2. Gallandat Huet RC, Siemons AW, Baus D, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth. 2000 ; 47: 1207-1215
3. Groeneveld AB, Navickis RJ, Wilkes MM. Update on the comparative safety of colloids: a systematic review of clinical studies. Ann Surg. 2011 ; 253: 470-483
4. Verheij J, van Lingen A, Beishuizen A, et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med. 2006 ; 32: 1030-1038
5. Fries D, Innerhofer P, Klingler A, et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg. 2002 ; 94: 1280-1287
6. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001 ; 29: 1261-1267
7. Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost. 2009 ; 7: 1099-1105
8. Schols SE, Feijge MA, Lance MD, et al. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets. Transfusion. 2008 ; 48: 2384-2394
9. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg. 2007 ; 105: 905-917
10. Appelman MH, van Barneveld LJ, Romijn JW, Vonk AB, Boer C. The impact of balanced hydroxylethyl starch cardiopulmonary bypass priming solution on the fibrin part of clot formation: ex vivo rotation thromboelastometry. Perfusion. 2011 ; 26: 175-180
11. Mardel SN, Saunders FM, Allen H, et al. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth. 1998 ; 80: 204-207
12. Boks RH, Wijers MJ, Hofland J, Takkenberg JJ, Bogers AJ. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference?. Perfusion. 2007 ; 22: 333-337
13. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?. Asian Cardiovasc Thorac Ann. 2009 ; 17: 368-372
14. Van der Linden PJ, De Hert SG, Deraedt D, et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg. 2005 ; 101: 629-634
15. Raja SG, Akhtar S, Shahbaz Y, Masood A. In cardiac surgery patients does Voluven(R) impair coagulation less than other colloids?. Interact Cardiovasc Thorac Surg. 2011 ; 12: 1022-1027
16. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth. 2010 ; 104: 691-697
17. Kasper SM, Meinert P, Kampe S, et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology. 2003 ; 99: 42-47
18. Theusinger OM, Nurnberg J, Asmis LM, Seifert B, Spahn DR. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg. 2010 ; 37: 677-683
19. Rahe-Meyer N, Solomon C, Vorweg M, et al. Multicentric comparison of single portion reagents and liquid reagents for thromboelastometry. Blood Coagul Fibrinolysis. 2009 ; 20: 218-222
20. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med. 1999 ; 25: 258-268
21. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012 ; 367: 124-134
22. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012 ; 367: 1901-1911
23. Van Der Linden P, James M, Mythen M, Weiskopf RB. Review article: safety of modern starches used during surgery. Anesth Analg. 2013 ; 116: 35-48